Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report for the period January – September 2016. The presentation will be held in English.

Time: Thursday November 3, 2016 at 10.00 a.m. CET.

Registration can preferably be done 10-15 minutes before the conference start time on:

Sweden dial in number: +46 (0)8 5052 0114 

UK dial in number: +44 (0)207 1620 177 

Conference name: Vitrolife, conference ID: 960496

Vitrolife participants:
Thomas Axelsson, CEO

Mikael Engblom, CFO

The press release for Vitrolife’s interim report will be released at 8.30 CET on the same day.

Before the conference call, slides will be available at the company web page, http://www.vitrolife.com

A recorded version of the presentation will be available for seven days on number 

+46 (0)8 5052 0333 (Sweden) or 020 7031 4064 (UK), access code 960496.

Gothenburg, July 7, 2016

VITROLIFE AB (publ)

For further information, please contact:
Mikael Engblom, CFO, 46 (0) 31 721 80 14

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

_________________________________________________________________________________________________________________

Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes

 Vitrolife has approximately 360 employees and the company's products are sold in almost 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary, Denmark and Germany. The Vitrolife share is listed on NASDAQ Stockholm, Mid Cap.

Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com. Website: www.vitrolife.com/

Tags: